CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 15.94
(2.57%)
HKD 15.94
(2.57%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 70.46 Million CNY | -27.7% |
| 2022 | 97.46 Million CNY | -6.9% |
| 2021 | 104.68 Million CNY | 302.69% |
| 2020 | 25.99 Million CNY | 21.9% |
| 2019 | 21.32 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 109.15 Million CNY | 0.0% |
| 2024 Q1 | 109.15 Million CNY | 0.0% |
| 2023 Q4 | 70.46 Million CNY | 0.0% |
| 2023 FY | 70.46 Million CNY | -27.7% |
| 2023 Q3 | 70.46 Million CNY | -21.6% |
| 2023 Q2 | 89.87 Million CNY | 0.0% |
| 2023 Q1 | 89.87 Million CNY | -7.78% |
| 2022 Q2 | 104.72 Million CNY | 0.0% |
| 2022 Q1 | 104.72 Million CNY | 0.04% |
| 2022 FY | 97.46 Million CNY | -6.9% |
| 2022 Q4 | 97.46 Million CNY | 0.0% |
| 2022 Q3 | 97.46 Million CNY | -6.94% |
| 2021 FY | 104.68 Million CNY | 302.69% |
| 2021 Q4 | 104.68 Million CNY | 0.0% |
| 2021 Q3 | 104.68 Million CNY | -13.88% |
| 2021 Q2 | 121.55 Million CNY | 0.0% |
| 2021 Q1 | 121.55 Million CNY | 367.58% |
| 2020 FY | 25.99 Million CNY | 21.9% |
| 2020 Q4 | 25.99 Million CNY | 0.0% |
| 2020 Q3 | 25.99 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 21.32 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 30.61 Million HKD | -130.197% |
| CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 98.351% |